SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from MiNK Therapeutics, (INKT) — Oct 12, 2021

MiNK Therapeutics, Inc.
Date: Oct. 12, 2021 · CIK: 0001840229 · Accession: 0001193125-21-296966

AI Filing Summary & Sentiment

File numbers found in text: 333-259503

Date
October 12, 2021
Author
Not clearly detected
Form
CORRESP
Company
MiNK Therapeutics, Inc.

Letter

MiNK Therapeutics, Inc.

149 Fifth Avenue, Suite 500

New York, NY 10010

October 12, 2021

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.

Attention: Dillon Hagius

Re: MiNK Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-259503)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 14, 2021, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please call Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663, as soon as the registration statement has been declared effective.

[Signature page follows]

Very truly yours,
MINK THERAPEUTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 MiNK Therapeutics, Inc.

149 Fifth Avenue, Suite 500

 New
York, NY 10010

 October 12, 2021

 VIA EDGAR

 Securities and Exchange Commission

 Division of
Corporation Finance

 100 F Street, N.E.

 Washington, D.C.
20549

 Attention:    Dillon Hagius

 Re:     MiNK Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-259503)

 Request for Acceleration

 Ladies and
Gentlemen:

 Pursuant to Rule 461 under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the
“Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 14, 2021, or as soon as possible
thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please call Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663, as
soon as the registration statement has been declared effective.

 [Signature page follows]

Very truly yours,

MINK THERAPEUTICS, INC.

By:

 /s/ Jennifer S. Buell

Name:

Jennifer S. Buell

Title:

President and Chief Executive Officer

 [Signature Page to Acceleration Request]